Biotech Stocks

Amarin (AMRN): Management Is Flying in the Dark

A lot of Amarin (AMRN) stock bulls expected shares to fly up toward $30 following shockingly good results of the company’s Reduce-It cardiovascular …

The Clock Is Ticking on Aptinyx (APTX) Stock; Cowen Weighs In

Wednesday turned out to be a nightmare for Aptinyx (APTX) investors, as the stock price crashed nearly 70% in the wake of clinical …

Amarin (AMRN) Stock: This Bull Isn’t Bullish Enough

Amarin (AMRN) has been Wall Street’s biggest standout of 2018, with shares skyrocketing nearly 240%. The biggest question for investors, then, is whether …

Bullish Analyst Ups Price Target on Axsome (AXSM) Stock as It Gets Closer in Bringing MDD Drug to Market

Axsome Therapeutics (AXSM) stock more than doubled since the drug maker announced positive results for its phase 2 trial, ASCEND on Monday. The …

La Jolla (LJPC) Stock Crashes — Is There a Light at the End of the Tunnel?

La Jolla’s (LJPC) shares lost almost half of their value Monday, after the company pre-announced fourth quarter revenues for its drug Giapreza – …

Analyst Cuts Price Target on Aphria (APHA) Stock Amid Recent Takeover Talks

Aphria (APHA) stock has been experiencing some turbulence ever since a short report came out in early December suggesting the company was benefiting …

Why Does This Analyst Upgrade Bausch Health (BHC) Stock After Years of Distrust?

Bausch Health (BHC) is getting a bit of special treatment. Following a tough run of negative sentiment toward the company, Piper Jaffray analyst David Amsellem …

Sesen (SESN) Stock Just Lost a Bull

Sesen (SESN) stock tumbled nearly 40% following lousy preliminary results for the company’s Phase 3 study of Vicinium for the treatment of Non-Muscle …

Celgene Corporation (CELG) Stock Looks Like a Winner

Celgene (CELG) stock jumped over 30% in the past few trading days — and with good reason. Investors are excited over what is …

GW Pharmaceuticals (GWPH) Stock Finds a Fan in J.P Morgan

J.P Morgan analyst Cory Kasimov initiates coverage for medical cannabis company GW Pharmaceuticals (GWPH), calling it a “clear leader” in the field of cannabinoid …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts